Vimarsana
Biggest News Aggregation in the World

Page 46 - Ioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ioscience Today - Breaking & Trending Today

After Pandemic Lull, Companies Continue To Eye Denver As Hub For Expansion - Vimarsana News

After Pandemic Lull, Companies Continue To Eye Denver As Hub For Expansion

Tech firms are leading the pack.

Source: bisnow.com
Meridian Bioscience: Fiscal Q1 Earnings Snapshot - Vimarsana News

Meridian Bioscience: Fiscal Q1 Earnings Snapshot

CINCINNATI _ Meridian Bioscience Inc. on Friday reported earnings of $15.3 million in its fiscal first quarter. The Cincinnati-based company said it had profit of 35 cents per... | February 4, 2022

Lexaria Bioscience Corp.: Lexaria Reports Potentially Ground-Breaking Findings in Sildenafil Animal Study - Vimarsana News

Lexaria Bioscience Corp.: Lexaria Reports Potentially Ground-Breaking Findings in Sildenafil Animal Study

DehydraTECHTM sildenafil delivered 74% more drug at 4 minutes, than the controlKELOWNA, BC / ACCESSWIRE / February 2, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria")

Arix Bioscience PLC: Clinical development update from portfolio company LogicBio - Vimarsana News

Arix Bioscience PLC: Clinical development update from portfolio company LogicBio

DJ Arix Bioscience PLC: Clinical development update from portfolio company LogicBio Arix Bioscience PLC (ARIX) Arix Bioscience PLC: Clinical development update from portfolio company LogicBio 02-Feb-2022

Twist Bioscience Corporation: Abcam Collaborates With Twist Bioscience to Enhance Antibody Discovery for Diagnostic and Research Applications - Vimarsana News

Twist Bioscience Corporation: Abcam Collaborates With Twist Bioscience to Enhance Antibody Discovery for Diagnostic and Research Applications

Abcam to license in VHH phage library(1) from Twist, complementing in-house recombinant antibody capabilities Abcam to develop and commercialize antibodies for diagnostic and research use